| Mr Andreas Johanes Thude, FNP | |
|
26700 S Us Highway 85, Buckeye, AZ 85326-5024 | |
| (623) 386-6160 | |
| Not Available |
| Full Name | Mr Andreas Johanes Thude |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 26700 S Us Highway 85, Buckeye, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336684075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP9684 (Arizona) | Primary |
| Entity Name | Honorhealth Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740273614 PECOS PAC ID: 0345130266 Enrollment ID: O20040316000867 |
News Archive
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Scientists predict that the world is due for an influenza pandemic - a global outbreak from a new strain of flu - that would have a dramatic impact on our nation's communities, schools, and families.
Javelin Pharmaceuticals, Inc. today announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska™ (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant. Previously, Javelin had reported that the top line results for its primary endpoint were not statistically significant.
Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of mutations correlates with early progression of the tumor and decreased survival.
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection and can serve as an alternative detection device.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Andreas Johanes Thude, FNP 2950 N Clanton St, Buckeye, AZ 85396-7703 Ph: (623) 201-9930 | Mr Andreas Johanes Thude, FNP 26700 S Us Highway 85, Buckeye, AZ 85326-5024 Ph: (623) 386-6160 |
News Archive
EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.
Scientists predict that the world is due for an influenza pandemic - a global outbreak from a new strain of flu - that would have a dramatic impact on our nation's communities, schools, and families.
Javelin Pharmaceuticals, Inc. today announced that a reexamination conducted by a third party of pain score measurements from its Phase III study of Ereska™ (intranasal ketamine) showed that top line results for its primary endpoint were statistically significant. Previously, Javelin had reported that the top line results for its primary endpoint were not statistically significant.
Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival and cell proliferation pathways. Increased accumulation of mutations correlates with early progression of the tumor and decreased survival.
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection and can serve as an alternative detection device.
› Verified 1 days ago
Carmela Marfori Fernandez, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 525 S Watson Rd Ste 200, Buckeye, AZ 85326 Phone: 623-385-7900 | |
Allison Stuart, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20460 W Legend Trl, Buckeye, AZ 85396 Phone: 928-504-4700 | |
Dr. Susan Thompson, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 26700 S Us Highway 85, Buckeye, AZ 85326 Phone: 623-386-6160 | |
Maria Lourdes Arndt, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 26721 W Mohawk Ln, Buckeye, AZ 85396 Phone: 928-533-9698 | |
Esther Wambura Burns, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 20751 W Market St, Buckeye, AZ 85396 Phone: 623-463-5000 | |
Elizabeth Vidales, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 306 E Monroe Ave, Buckeye, AZ 85326 Phone: 877-809-5092 | |
Ms. Eva Socorro Mijares, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 410 E Mc 85, Buckeye, AZ 85326 Phone: 602-363-3438 Fax: 602-584-3677 |